{
    "medicine_id": "49a1377be04bb291bc2ab02d8eead438191d2149",
    "platform_id": "DB05476",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v WX UK1",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in solid tumors",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "WX UK1 is a 3 amidinophenylalanine based non cytotoxic small molecule that belongs to a new class of drugs In animal models WX UK1 blocks tumor cell invasion metastasis and primary tumor growth by inhibiting serine proteases and the urokinase Plasminogen Activator uPA system which have been shown to play a key role in metastasis and primary tumor growth of breast gastric colon cancer and various other solid tumors",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}